Literature DB >> 15661273

Chronic myeloid leukemia following kidney transplantation.

Luís Arthur Flores Pelloso1, Mireille Guimarães Vaz de Campos, Marília Nascimento, Maria Regina Régis Silva, José Osmar Medina Pestana, Maria de Lourdes L F Chauffaille.   

Abstract

Immunosuppressed renal recipients are at an increased risk of developing cancer. Leukemias are less frequent than other hematopoietic tumours and development of CML after immunosuppression is rare. We describe a 37-year-old male who presented with left-shifted leukocytosis, hypercellular bone marrow 32 months after the kidney transplant. G-banding karyotype revealed 46,XY,t(9;22)(q34;q11) and the diagnosis of chronic myeloid leukemia was made. This is the 13th case of CML after kidney transplant reported. Whether this CML appeared as a random phenomenon or chemically induced is a matter of debate. Some individuals might have an increased susceptibility to the effects of azathioprine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661273     DOI: 10.1016/j.leukres.2004.07.008

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  Investigation on the interaction behavior of afatinib, dasatinib, and imatinib docked to the BCR-ABL protein.

Authors:  Kelvyn M L Rocha; Érica C M Nascimento; João B L Martins
Journal:  J Mol Model       Date:  2021-10-01       Impact factor: 1.810

Review 2.  Hematologic abnormalities following renal transplantation.

Authors:  Mark A Marinella
Journal:  Int Urol Nephrol       Date:  2009-03-20       Impact factor: 2.266

3.  Clinical lessons to be learned from patients developing chronic myeloid leukemia while on immunosuppressive therapy after solid organ transplantation: yet another case after orthotopic heart transplantation.

Authors:  Christian Oberender; Lorenz Kleeberg; Nicola Nienhues; Martin Gresse; Bernd Dörken; Hanno Riess; Philipp le Coutre
Journal:  Case Rep Hematol       Date:  2014-11-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.